Diabetes Drug vs. Cancer

Print pagePDF pageEmail page

Diabetes Drug vs. Cancer

Considerable evidence has indicated that a drug used for more than 50 years to treat Type 2 diabetes can also prevent or slow the growth of certain cancers. But the mechanism behind metformin’s anticancer effects has been unknown.






Now, a team of Harvard Medical School investigators at Massachusetts General Hospital has identified a pathway that appears to underlie metformin’s ability both to block the growth of human cancer cells and to extend the lifespan of the C. elegans roundworm. Their findings imply that this single genetic pathway plays an important role in a wide range of organisms.



Harvard Medical School

Key Words: Diabetes, Cancer, Drug, Metformin

Leave a Reply

Time limit is exhausted. Please reload CAPTCHA.